Understanding Recovery in Pediatric Complex Regional Pain Syndrome (CRPS)
This study is looking at children aged 10 to 17 with Complex Regional Pain Syndrome (CRPS), a severe and complex chronic pain condition. Researchers want to understand what factors, including brain changes and personal experiences, predict how well children recover from CRPS. You would participate in three sessions, which include psychosocial measures (like questionnaires about feelings and experiences), brain imaging, and sensory tests. Parents also complete three sessions of psychosocial measures. The study aims to see how pain perception and ability to function change over time, both before and after usual CRPS treatment, and up to six months later. This is an observational study, meaning it doesn't involve new treatments, but rather observes patients undergoing their regular care.
- Study design
- This is an observational study involving 126 participants. It is not randomized or blinded.
- What's involved
- Child participants will have three sessions involving psychosocial measures, brain imaging, and quantitative sensory testing. Parent participants will complete three sessions of psychosocial measures.
- Compensation
- Not stated in the trial record.
- Follow-up
- Pain perception and functional disability will be measured up to six months after treatment for patients, and six months after the second session for healthy participants.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Markers of Trajectory in Pediatric CRPS
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Robert C Coghill, PhD · PRINCIPAL_INVESTIGATOR · Children's Hospital, Cincinnati
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- changes in pain perceptionbefore treatment, at the end of the treatment (an average of 4 weeks for inpatients and 3 months for outpatients after session 1), and 6-month post treatment for patients; 1 month after session 1 and 6 months after session 2 for healthy participants
changes in ratings of spontaneous pain intensity and unpleasantness assessed on non-numerical visual analog scales, ranging from 'no pain sensation'/'not at all unpleasant' to 'most intense pain sensation imaginable'/'most unpleasant imaginable'
- Changes in functional disabilitybefore treatment, at the end of the treatment (an average of 4 weeks for inpatients and 3 months for outpatients after session 1), and 6-month post treatment for patients; 1 month after session 1 and 6 months after session 2 for healthy participants
Changes in scores on the self-reported Functional Disability Inventory investigates disabilities associated with pain which might impact on everyday functioning of children. It includes 15 questions assessing the children's capacity to perform everyday tasks, such as doing chores, walking, or eating regular meals. Participants evaluate their capacity to perform these tasks on Likert-type scale, ranging from "No Trouble" to "Impossible".